BACKGROUND: The effect of prior hepatitis B virus (HBV) infection on the clinicopathologic findings for patients with hepatitis C virus (HCV) RNA and hepatocellular carcinoma (HCC) is still unclear. METHODS: Of 59 patients who underwent liver resection for HCV-related HCC (</=2.0 cm in greatest dimension) without metastases between 1990 and 1997, 38 patients had anti-HB core antibody (anti-HBc) and did not have HB surface antigen in their sera (Group 1). Their clinicopathologic findings and outcomes after surgery were compared with those of the remaining 22 patients without anti-HBc (Group 2). RESULTS: The proportion of well-differentiated HCC was significantly lower in Group 1 than in Group 2 (P = 0.0214). The percentage of patients with cirrhosis was significantly lower in Group 1 than in Group 2 (P = 0.0228). The cumulative survival rate was significantly lower in Group 1 than in Group 2 (P = 0.0224). The risk ratio of anti-HBc for shorter survival time was 3.817. CONCLUSIONS: HCC more often developed before cirrhosis in patients with HCV RNA and anti-HBc than in patients positive for HCV RNA alone. Prior HBV infection was a risk factor for poor outcome after liver resection for patients infected with HCV. Copyright 1999 American Cancer Society.
BACKGROUND: The effect of prior hepatitis B virus (HBV) infection on the clinicopathologic findings for patients with hepatitis C virus (HCV) RNA and hepatocellular carcinoma (HCC) is still unclear. METHODS: Of 59 patients who underwent liver resection for HCV-related HCC (</=2.0 cm in greatest dimension) without metastases between 1990 and 1997, 38 patients had anti-HB core antibody (anti-HBc) and did not have HB surface antigen in their sera (Group 1). Their clinicopathologic findings and outcomes after surgery were compared with those of the remaining 22 patients without anti-HBc (Group 2). RESULTS: The proportion of well-differentiated HCC was significantly lower in Group 1 than in Group 2 (P = 0.0214). The percentage of patients with cirrhosis was significantly lower in Group 1 than in Group 2 (P = 0.0228). The cumulative survival rate was significantly lower in Group 1 than in Group 2 (P = 0.0224). The risk ratio of anti-HBc for shorter survival time was 3.817. CONCLUSIONS: HCC more often developed before cirrhosis in patients with HCV RNA and anti-HBc than in patients positive for HCV RNA alone. Prior HBV infection was a risk factor for poor outcome after liver resection for patients infected with HCV. Copyright 1999 American Cancer Society.
Authors: S Kubo; A Tamori; K Ohba; T Shuto; T Yamamoto; H Tanaka; S Nishiguchi; K Wakasa; K Hirohashi; H Kinoshita Journal: Dig Dis Sci Date: 2001-11 Impact factor: 3.199
Authors: Jeffrey D Wayne; Gregory Y Lauwers; Iwao Ikai; Dorota A Doherty; Jacques Belghiti; Yoshio Yamaoka; Jean-Marc Regimbeau; David M Nagorney; Kim-Anh Do; Lee M Ellis; Steven A Curley; Raphael E Pollock; Jean-Nicolas Vauthey Journal: Ann Surg Date: 2002-05 Impact factor: 12.969
Authors: Timothy M Pawlik; Ronnie T Poon; Eddie K Abdalla; Juan M Sarmiento; Iwao Ikai; Steven A Curley; David M Nagorney; Jacques Belghiti; Irene Oi-Lin Ng; Yoshio Yamaoka; Gregory Y Lauwers; Jean-Nicolas Vauthey Journal: J Gastrointest Surg Date: 2004-11 Impact factor: 3.452
Authors: Emily C Bellavance; Kimberly M Lumpkins; Gilles Mentha; Hugo P Marques; Lorenzo Capussotti; Carlo Pulitano; Pietro Majno; Paulo Mira; Laura Rubbia-Brandt; Alessandro Ferrero; Luca Aldrighetti; Steven Cunningham; Nadia Russolillo; Benjamin Philosophe; Eduardo Barroso; Timothy M Pawlik Journal: J Gastrointest Surg Date: 2008-08-15 Impact factor: 3.452
Authors: Nestor F Esnaola; Nadeem Mirza; Gregory Y Lauwers; Iwao Ikai; Jean-Marc Regimbeau; Jacques Belghiti; Yoshio Yamaoka; Steven A Curley; Lee M Ellis; David M Nagorney; Jean-Nicolas Vauthey Journal: Ann Surg Date: 2003-11 Impact factor: 12.969
Authors: Ryan T Groeschl; Johnny C Hong; Kathleen K Christians; Kiran K Turaga; Susan Tsai; Charles H C Pilgrim; T Clark Gamblin Journal: HPB (Oxford) Date: 2013-06-19 Impact factor: 3.647
Authors: Tali Shaltiel; Serena Zheng; Cleo Siderides; Elizabeth M Gleeson; Jacquelyn Carr; Eric R Pletcher; Noah A Cohen; Benjamin J Golas; Deepa R Magge; Daniel M Labow; Andrea D Branch; Umut Sarpel Journal: Cancer Date: 2021-02-25 Impact factor: 6.921